Equities

RADNOSTIX, INC.

  • Add to watchlist
  • Add to portfolio
  • Add an alert
INIS:QBB

RADNOSTIX, INC.

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.0922
  • Today's Change0.025 / 36.65%
  • Shares traded3.16k
  • 1 Year change+77.86%
  • Beta1.2246
Data delayed at least 15 minutes, as of Feb 13 2026 20:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Radnostix, Inc., formerly International Isotopes Inc., manufactures a wide range of radioisotope-focused products. The Company manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer. The Company provides contract manufacturing of various drug products as well as radioisotope active pharmaceutical ingredient (API) supply for third party theranostics clients. The Company manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and single photon emission computed tomography (SPECT)/positron emission tomography (PET) imaging systems as well as industrial calibration standards under its RadQual brand. The Company also manufactures Cobalt-60 sealed source products.

  • Revenue in USD (TTM)14.07m
  • Net income in USD-231.26k
  • Incorporated1995
  • Employees41.00
  • Location
    RADNOSTIX, INC.4137 Commerce CircleIDAHO FALLS 83401United StatesUSA
  • Phone+1 (208) 524-5300
  • Fax+1 (208) 524-1411
  • Websitehttps://radnostix.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Celularity Inc40.58m-80.71m36.48m123.00------0.899-3.34-3.341.69-0.71210.33396.145.24329,902.40-66.35-23.42-158.76-26.8350.61---198.75-294.700.123-6.572.01--138.11--70.51------
Telomir Pharmaceuticals Inc0.00-11.25m37.48m----5.28-----0.3739-0.37390.000.20630.00-------266.47---303.19--------------0.00-------26.48------
Talphera Inc28.00k-12.46m37.79m13.00--1.93--1,349.68-0.3808-0.3780.00090.42070.0011----2,153.85-48.15-14.86-54.44-19.40-----44,503.57-446.19----0.00---100.00---26.41------
Earth Science Tech Inc33.84m2.81m38.01m76.0014.087.6112.301.120.00920.00920.11140.01714.9312.73156.99445,269.5040.5624.0466.31--72.2171.088.225.500.72027.060.009--177.05128.98300.63------
Rockwell Medical Inc75.58m-5.48m39.80m244.00--1.08--0.5266-0.1583-0.15832.200.93951.3212.928.78309,741.80-9.63-32.92-12.15-46.6115.818.00-7.30-23.863.50-6.130.2141--21.3810.6194.31--11.47--
BioScience Health Innovations Inc4.73m885.68k43.92m--206.5025.67--9.290.01940.01940.13130.15583.814.3099.37--71.34--85.11--63.64--18.74--3.47--0.00--208.73--134.59------
Elutia Inc21.08m-22.99m44.84m51.00------2.13-0.6006-0.68270.5347-1.030.54194.046.50413,411.80-59.08-57.79---128.4145.9742.77-109.03-92.860.396-------1.50-10.69-31.23--2.54--
Zhengye Biotechnology Holding Ltd22.25m-2.80m45.54m277.00--1.05134.802.05-0.059-0.0590.47870.91310.30991.622.0480,341.63-4.60---7.79--37.37---14.83--1.10-7.000.1902---11.95---64.04------
RADNOSTIX, INC.14.07m-231.26k48.72m41.00--11.89289.473.46-0.0004-0.00040.02680.00780.81475.968.18343,260.30-1.341.32-1.681.9559.8959.45-1.641.951.06-0.29280.59540.0013.319.19100.99--28.22--
Odonate Inc0.00-102.07m52.65m137.00--2,022.38-----108.70-108.700.0074.170.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
Nasus Pharma Ltd0.00-1.19m53.18m-----------0.1319-0.13830.00-0.47620.00-------373.32-----------------2.51---------54.23------
Janel Corp207.44m5.03m56.94m353.0011.502.216.620.27454.184.18172.0921.751.4732.804.14587,657.304.021.7613.355.3331.3326.692.730.96080.70133.100.39130.0013.2420.272,155.61---14.58--
Cumberland Pharmaceuticals, Inc.41.28m-3.33m58.03m91.00--2.2245.991.41-0.2331-0.23312.791.750.57881.723.80453,608.30-4.68-6.88-7.60-9.6584.4980.74-8.09-15.891.11-28.410.1688---4.261.95-3.19---29.32--
ImmuCell Corp27.77m2.32m59.70m70.0025.512.0011.892.150.25880.25883.093.290.61591.9011.42402,453.605.15-5.355.69-5.7740.9336.028.37-11.871.766.470.2415--51.6414.0662.65---19.66--
Data as of Feb 13 2026. Currency figures normalised to RADNOSTIX, INC.'s reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Capital Square LLCas of 31 Dec 202520.00k0.00%
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.